As Myriad Genetics (MYGN) Market Value Rose, Consonance Capital Management LP Boosted Its Position by $7.28 Million; As Disney/The Walt/Co. (DIS) Market Value Declined, Bath Savings Trust Co Has Raised Stake by $454,210

October 7, 2017 - By Linda Rogers

Bath Savings Trust Co increased its stake in Disney/The Walt/Co. (DIS) by 6.2% based on its latest 2017Q2 regulatory filing with the SEC. Bath Savings Trust Co bought 4,285 shares as the company’s stock declined 2.31% while stock markets rallied. The institutional investor held 73,382 shares of the television services company at the end of 2017Q2, valued at $7.80M, up from 69,097 at the end of the previous reported quarter. Bath Savings Trust Co who had been investing in Disney/The Walt/Co. for a number of months, seems to be bullish on the $154.39B market cap company. The stock decreased 0.04% or $0.04 on October 6, reaching $100.07. About 4.36M shares traded. Walt Disney Co (NYSE:DIS) has risen 9.26% since October 7, 2016 and is uptrending. It has underperformed by 7.44% the S&P500.

Mitchell Blutt increased its stake in Myriad Genetics Inc (MYGN) by 9.78% based on its latest 2017Q2 regulatory filing with the SEC. Consonance Capital Management Lp bought 291,131 shares as the company’s stock rose 13.21% with the market. The hedge fund run by Mitchell Blutt held 3.27M shares of the health care company at the end of 2017Q2, valued at $84.43 million, up from 2.98M at the end of the previous reported quarter. Consonance Capital Management Lp who had been investing in Myriad Genetics Inc for a number of months, seems to be bullish on the $2.59 billion market cap company. The stock increased 1.73% or $0.63 on October 6, reaching $37.14. About 824,172 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 37.47% since October 7, 2016 and is downtrending. It has underperformed by 54.17% the S&P500.

Among 37 analysts covering The Walt Disney Company (NYSE:DIS), 21 have Buy rating, 3 Sell and 13 Hold. Therefore 57% are positive. The Walt Disney Company had 124 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Macquarie Research with “Outperform” on Tuesday, September 1. UBS maintained Walt Disney Co (NYSE:DIS) on Thursday, September 29 with “Buy” rating. Jefferies maintained the shares of DIS in report on Thursday, June 1 with “Hold” rating. The stock of Walt Disney Co (NYSE:DIS) earned “Market Perform” rating by Bernstein on Thursday, August 20. As per Monday, August 10, the company rating was maintained by Deutsche Bank. Piper Jaffray maintained the stock with “Buy” rating in Sunday, August 6 report. The stock of Walt Disney Co (NYSE:DIS) earned “Buy” rating by RBC Capital Markets on Monday, June 12. The company was maintained on Friday, September 23 by CLSA. The company was upgraded on Friday, January 6 by RBC Capital Markets. The rating was initiated by Credit Agricole on Wednesday, September 2 with “Outperform”.

Investors sentiment increased to 1.09 in 2017 Q2. Its up 0.17, from 0.92 in 2017Q1. It increased, as 77 investors sold DIS shares while 606 reduced holdings. 108 funds opened positions while 638 raised stakes. 920.44 million shares or 3.28% less from 951.70 million shares in 2017Q1 were reported. Van Eck Associates reported 277,262 shares. Hollencrest Limited Liability Com reported 4,745 shares or 0.08% of all its holdings. Prudential Public Limited Liability Com holds 0.28% of its portfolio in Walt Disney Co (NYSE:DIS) for 808,392 shares. Mu Company Limited accumulated 0.04% or 570 shares. 15,468 were accumulated by Natixis Asset Management. Advisor Prtn Limited Liability Corporation has 27,003 shares. Sva Plumb Wealth Limited Liability Corp, Wisconsin-based fund reported 67,892 shares. John G Ullman And Associates owns 3,706 shares. Johnson Invest Counsel has invested 0.62% of its portfolio in Walt Disney Co (NYSE:DIS). Brown Advisory has 2.39M shares. Cetera Advisor Netwr Limited Company invested in 57,410 shares or 0.29% of the stock. Ramsay Stattman Vela & Price holds 2.74% or 59,251 shares. Evergreen Capital Management Limited Liability Corp has 16,169 shares for 0.28% of their portfolio. Chesley Taft And Assoc Llc has invested 1.78% in Walt Disney Co (NYSE:DIS). Rodgers Brothers Incorporated owns 20,961 shares for 0.82% of their portfolio.

More notable recent Walt Disney Co (NYSE:DIS) news were published by: Investorplace.com which released: “CEO Bob Iger to (Finally) Leave Walt Disney Co (DIS) in 2019” on October 04, 2017, also Newsday.com with their article: “Altice, Disney announce tentative deal for Optimum customers” published on October 02, 2017, Reuters.com published: “Walt Disney threatens to pull ESPN, ABC from Optimum” on September 25, 2017. More interesting news about Walt Disney Co (NYSE:DIS) were released by: Investorplace.com and their article: “Walt Disney Co (DIS) Stock Holders Are Overreacting” published on October 06, 2017 as well as Fool.com‘s news article titled: “Is Walt Disney Co. Losing Its Magic?” with publication date: September 12, 2017.

Bath Savings Trust Co, which manages about $360.51 million US Long portfolio, decreased its stake in Apple Computer (NASDAQ:AAPL) by 2,093 shares to 120,525 shares, valued at $17.36M in 2017Q2, according to the filing. It also reduced its holding in Vf Corp (NYSE:VFC) by 6,650 shares in the quarter, leaving it with 12,533 shares, and cut its stake in Tractor Supply Company (NASDAQ:TSCO).

Since May 11, 2017, it had 0 buys, and 1 insider sale for $1.32 million activity.

Another recent and important Myriad Genetics, Inc. (NASDAQ:MYGN) news was published by Globenewswire.com which published an article titled: “Myriad Genetics to Present Three Studies at the 2017 National Society of …” on September 12, 2017.

Among 19 analysts covering Myriad Genetics (NASDAQ:MYGN), 2 have Buy rating, 4 Sell and 13 Hold. Therefore 11% are positive. Myriad Genetics has $52 highest and $15 lowest target. $30.13’s average target is -18.87% below currents $37.14 stock price. Myriad Genetics had 43 analyst reports since July 21, 2015 according to SRatingsIntel. Deutsche Bank upgraded the stock to “Hold” rating in Friday, August 18 report. The stock has “Equal-Weight” rating by Stephens on Wednesday, November 2. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) has “Buy” rating given on Thursday, January 7 by Deutsche Bank. The firm has “Hold” rating by Cowen & Co given on Friday, September 15. The firm has “Sell” rating by Ladenburg Thalmann given on Monday, October 10. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) has “Market Outperform” rating given on Wednesday, May 4 by Avondale. On Wednesday, May 4 the stock rating was maintained by Leerink Swann with “Market Perform”. The rating was maintained by Piper Jaffray on Tuesday, September 15 with “Overweight”. Cowen & Co maintained the stock with “Hold” rating in Monday, August 14 report. The rating was maintained by Piper Jaffray on Tuesday, August 8 with “Hold”.

Investors sentiment decreased to 1.02 in Q2 2017. Its down 0.71, from 1.73 in 2017Q1. It is negative, as 28 investors sold MYGN shares while 74 reduced holdings. 45 funds opened positions while 59 raised stakes. 78.85 million shares or 1.67% less from 80.18 million shares in 2017Q1 were reported. Commerzbank Aktiengesellschaft Fi owns 20,000 shares for 0.01% of their portfolio. First Trust Advsr Lp holds 1.84 million shares. Baillie Gifford &, United Kingdom-based fund reported 9.67M shares. Ameriprise Fincl reported 0.01% stake. Goldman Sachs Gp Incorporated holds 1.00 million shares or 0.01% of its portfolio. Public Employees Retirement Association Of Colorado invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Sterling Capital Mgmt Ltd Liability has invested 0.46% in Myriad Genetics, Inc. (NASDAQ:MYGN). Phocas, a California-based fund reported 120 shares. Proshare Advsrs invested in 43,079 shares. Shell Asset Management has 40,846 shares for 0.03% of their portfolio. Cs Mckee Lp invested 0.06% in Myriad Genetics, Inc. (NASDAQ:MYGN). Consonance Mngmt Limited Partnership owns 3.27M shares. Us Natl Bank De invested in 0% or 1,787 shares. Susquehanna Group Llp accumulated 43,846 shares or 0% of the stock. State Of Alaska Department Of Revenue owns 13,452 shares or 0.02% of their US portfolio.

Consonance Capital Management Lp, which manages about $513.80M and $848.70 million US Long portfolio, decreased its stake in Globus Med Inc (NYSE:GMED) by 100,000 shares to 2.84 million shares, valued at $93.98M in 2017Q2, according to the filing. It also reduced its holding in Amarin Corp Plc (NASDAQ:AMRN) by 228,100 shares in the quarter, leaving it with 24.82M shares, and cut its stake in Seaspine Hldgs Corp.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com